AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The Australian market settled in red on 12th March 2020, where S&P/ASX200 closed at 5304.6, reflecting a fall of 7.36% or 421.3 points. Every sector on Australian Stock Exchange settled in red including S&P/ASX 200 Health Care (Sector), which tumbled by 3012 points to 39,461.9. S&P/ASX 200 Materials (Sector) settled at 10,236.0 with a fall of 7.45%. At the close of same trading day, All Ordinaries closed at 5370.9 with a decline of 418.4 points.
Following the heavy fall in equity market, two companies closed in green on ASX. CIMIC Group Limited (ASX: CIM) ended at $20.210 per share, reflecting a rise of 2.174% on an intraday basis. Pro Medicus Limited (ASX: PME) inched up by 1.261% to $16.860 per share.
S&P/NZX50 stood at 10,333 implying a fall of 5.33%. Moreover, Comvita Limited (NZX: CVT) settled at NZ$2.000 with an increase of 3.63%. QEX Logistics Limited (NZX: QEX) surged by 3.45% and reached at NZ$0.600 per share. On the other side, Moa Group Limited (NZX: MOA) plunged by 19.57% and stood at NZ$0.185 per share.
Recently, we have provided important information on Triangle Energy (Global) Limited (ASX:TEG). Readers can view the article by clicking here.
CIMIC Group Limited closed in green on Australian Stock Exchange
CIMIC Group Limited (ASX:CIM), on 11th March 2020, announced that its group company UGL has secured two rail sector contracts, which will generate a revenue of over $180 million. Moreover, UGL has been given contract by Qube Logistics for manufacturing new locomotives over the period of 18 months. As per the key personnel of UGL, these contracts will help in expanding its light rail capability along with heavy rail presence in Adelaide. These contracts would also commence its relationship with Qube Logistics. CIMIC Group company, UGL possesses strong reputation in terms of safety and quality. The company would be conducting its 2019 Annual General Meeting on 1st April 2020.
Pro Medicus Limited Rose by 1.261% on 12th March 2020.
Pro Medicus Limited (ASX:PME) recently notified the market with the results for the first half of financial year 2020, wherein, it reported revenue amounting to $29.3 million, reflecting a rise of 15.7% along with the net profit after tax of $12.1 million. As at 31st December 2019, the cash reserves of the company stood at $38.8m, indicating an increase of 20.2% despite a bigger dividend, a share buy-back as well as increased tax payments. The company ended the period in a debt-free position. To please the shareholders, PME announced a fully franked interim dividend of 6 cents per share.
On the operational front, the company secured two contracts, out of which one was with Ohio State University Wexler Medical Center of $9 million with the tenure of five-year. PME inked another contract of $6 million with Nines Inc.
